0690.HK Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 apr 2024 @ 04:02):

Stats
Dagens volum	100 000
Gjennomsnittsvolum	5.94M
Markedsverdi	540.91M
EPS	HKD0 ( 2023-08-28 )
Neste inntjeningsdato	( HKD0 ) 2024-05-16
Last Dividend	HKD0.00224 ( 2007-08-22 )
Next Dividend	HKD0 ( N/A )
P/E	8.90
ATR14	HKD0.00100 (1.12%)

Uni-Bio Science Group Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Uni-Bio Science Group Økonomi

Annual	2023
Omsetning:	HKD484.72M
Bruttogevinst:	HKD390.46M (80.55 %)
EPS:	HKD0.0111

FY	2023
Omsetning:	HKD484.72M
Bruttogevinst:	HKD390.46M (80.55 %)
EPS:	HKD0.0111

FY	2022
Omsetning:	HKD440.32M
Bruttogevinst:	HKD334.88M (76.06 %)
EPS:	HKD0.00600

FY	2021
Omsetning:	HKD353.41M
Bruttogevinst:	HKD277.01M (78.38 %)
EPS:	HKD-0.00306

Financial Reports:

No articles found.

Uni-Bio Science Group Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)

Uni-Bio Science Group Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 4.43 - Potential for dividend initiation, but uncertain (11.38%)

Information

First Dividend	HKD0.00224	2007-08-22
Last Dividend	HKD0.00224	2007-08-22
Next Dividend	HKD0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	1	--
Total Paid Out	HKD0.00224	--
Avg. Dividend % Per Year	0.00%	--
Score	2.39	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	4.43
Div. Directional Score	7.92	--

Next Divdend (Est)
(2024-04-29)

HKD0 Estimate 0.00 %

Dividend Stability

0.00 Very Bad

Dividend Score

2.39

Pay Frequency

Insufficient data to determine frequency

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for HKSE

Symbol	Title	Last dividend	Frequency	Yearly Dividend
2883.HK	Ex Dividend Knight	2023-06-07	Annually	0.00%
1480.HK	Ex Dividend Knight	2023-06-08	Sporadic	0.00%
0551.HK	Ex Dividend Junior	2023-09-12	Annually	0.00%
8053.HK	No Dividend Player	2023-09-28	Annually	0.00%
2001.HK	Ex Dividend Knight	2023-09-01	Annually	0.00%
1072.HK	Ex Dividend Junior	2023-06-30	Sporadic	0.00%
0151.HK	Ex Dividend Knight	2023-08-24	Semi-Annually	0.00%
3669.HK	Ex Dividend Junior	2023-09-07	Annually	0.00%
1635.HK	Ex Dividend Junior	2023-06-30	Annually	0.00%
0686.HK	Ex Dividend Junior	2023-06-29	Sporadic	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.146	1.500	7.08	10.00	[0 - 0.5]
returnOnAssetsTTM	0.259	1.200	1.356	1.628	[0 - 0.3]
returnOnEquityTTM	0.441	1.500	6.21	9.31	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	2.07	0.800	4.63	3.70	[1 - 3]
quickRatioTTM	1.870	0.800	3.71	2.96	[0.8 - 2.5]
cashRatioTTM	1.126	1.500	4.86	7.28	[0.2 - 2]
debtRatioTTM	0.112	-1.500	8.14	-10.00	[0 - 0.6]
interestCoverageTTM	139.39	1.000	10.00	10.00	[3 - 30]
operatingCashFlowPerShareTTM	0.0180	2.00	9.99	10.00	[0 - 30]
freeCashFlowPerShareTTM	0.0180	2.00	9.99	10.00	[0 - 20]
debtEquityRatioTTM	0.178	-1.500	9.29	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.807	1.000	10.00	10.00	[0.2 - 0.8]
operatingProfitMarginTTM	0.150	1.000	9.00	9.00	[0.1 - 0.6]
cashFlowToDebtRatioTTM	2.50	1.000	10.00	10.00	[0.2 - 2]
assetTurnoverTTM	1.773	0.800	1.511	1.209	[0.5 - 2]
Total Score				11.41

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	5.09	1.000	9.59	0	[1 - 100]
returnOnEquityTTM	0.441	2.50	7.56	9.31	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.0180	2.00	9.99	10.00	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0.0180	2.00	9.99	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0.116	1.500	-2.56	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.158	1.000	8.56	0	[0.1 - 0.5]
Total Score				4.43

Uni-Bio Science Group

Uni-Bio Science Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of biological and chemical pharmaceutical products to treat human diseases in the People's Republic of China. The company provides GeneTime, a prescription biological drug for wound healing; GeneSoft, an EGF eye drop for dry eye syndrome, corneal damage, and post-operative healing; Pinup, a voriconazole tablet to treat severe fungal infections; and Bokangtai, a mitiglinide tablet for the treatment of Type 2 diabetes, as well as Boshutai, an oral anti-diabetic drug targeting patients with pre-diabetes condition. It is also developing prescription drugs, including rExendin-4 (Uni-E4) for Type 2 diabetes; and rhPTH 1-34 (Uni-PTH) for the treatment of osteoporosis in postmenopausal women, as well as Uni-GLP, a GLP-1 agonist, a non-insulin treatment candidate for the treatment of Type 2 diabetes. The company was founded in 2001 and is headquartered in Sha Tin, Hong Kong.